ATE239037T1 - Zusammensetzung zur behandlung von nierenversagen - Google Patents

Zusammensetzung zur behandlung von nierenversagen

Info

Publication number
ATE239037T1
ATE239037T1 AT96201536T AT96201536T ATE239037T1 AT E239037 T1 ATE239037 T1 AT E239037T1 AT 96201536 T AT96201536 T AT 96201536T AT 96201536 T AT96201536 T AT 96201536T AT E239037 T1 ATE239037 T1 AT E239037T1
Authority
AT
Austria
Prior art keywords
composition
treatment
kidney failure
amino acids
enteral composition
Prior art date
Application number
AT96201536T
Other languages
English (en)
Inventor
Shen-Youn Chang
Dave C Madsen
Susan L Trimbo
Hugh N Tucker
Diana Twyman
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE239037T1 publication Critical patent/ATE239037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
AT96201536T 1995-06-06 1996-06-04 Zusammensetzung zur behandlung von nierenversagen ATE239037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/470,985 US5728678A (en) 1995-06-06 1995-06-06 Method and composition for providing nutrition to a renal failure patient

Publications (1)

Publication Number Publication Date
ATE239037T1 true ATE239037T1 (de) 2003-05-15

Family

ID=23869841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96201536T ATE239037T1 (de) 1995-06-06 1996-06-04 Zusammensetzung zur behandlung von nierenversagen

Country Status (7)

Country Link
US (1) US5728678A (de)
EP (1) EP0747395B1 (de)
JP (1) JPH0920678A (de)
AT (1) ATE239037T1 (de)
CA (1) CA2177195C (de)
DE (1) DE69627748T2 (de)
ES (1) ES2198459T3 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029252A1 (en) * 1994-04-21 1995-11-02 Ivan Lubomirov Stoilov Oral preparation for patients with chronic renal insufficiency and other protein metabolic diseases
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
DE69839922D1 (de) * 1998-01-05 2008-10-02 Univ Johns Hopkins Diätetische ergänzung für dialyse patienten
AU2217399A (en) * 1998-01-07 1999-07-26 Mark E. Jarmel Promoting mobilization and catabolism of lipids
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
ATE228779T1 (de) * 1999-01-20 2002-12-15 Nutricia Nv Säuglingsnährpräparat
EP1023843B1 (de) * 1999-01-29 2005-06-22 Sportmedizin Team Vertriebs GmbH Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
DK1048226T3 (da) * 1999-04-29 2005-10-03 Nestle Sa Sammensætning til spædbörnsernæring indeholdende proteiner fra söd valle
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
BR0010125A (pt) * 1999-04-29 2002-01-15 Nestle Sa Composição para uma fórmula para lactente tendo um baixo teor de treonina
DE60030722T2 (de) * 1999-07-16 2007-09-20 Biosynthema, Inc. Hemmung der aufnahme schädigender proteine durch die nieren mit einer kombination von lysin und arginin
EP1218039B1 (de) * 1999-09-22 2009-02-18 Advanced Renal Technologies Anwendung eines dialysats mit hohem zitratgehalt
CA2399063C (en) * 2000-02-04 2014-01-28 Societe Des Produits Nestle S.A. A method for maintaining or improving the synthesis of mucins
US6833350B2 (en) * 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US6995166B1 (en) 2000-09-27 2006-02-07 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiencies in renal patients
US7696219B2 (en) * 2000-09-27 2010-04-13 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiences in renal patients
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
KR100852930B1 (ko) * 2001-06-08 2008-08-19 리가가쿠 겐큐쇼 체온 상승성 아미노산군 의료용 제제
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
AU2003227475A1 (en) * 2002-04-09 2003-10-20 Eisai Co., Ltd. Drug containing riboflavin compound
JP4970694B2 (ja) 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
DK1737304T3 (da) * 2004-04-09 2014-07-28 Nutricia Nv Flydende koncentreret formel
EP1781282A4 (de) * 2004-07-23 2010-09-01 Dpi Solutions Inc Zusammensetzung zur stabilisierung von vitamin c in wasserphase und diese verwendendes verfahren zur stabilisierung von vitamin c
FR2875680B1 (fr) * 2004-09-29 2010-08-20 Veronique Marie-Pierre Peyrusson Compose dietetique pour combattre le syndrome metabolique
DK1983849T3 (da) 2006-01-20 2013-07-08 Innova Food Ab Fødevaresammensætning omfattende aminosyrer
BRPI0818301B1 (pt) * 2007-10-04 2022-02-15 Société des Produits Nestlé S.A. Composições para intensificar a função cognitiva, seu uso e seu método de fabricação, e kit
RU2482705C2 (ru) 2007-12-05 2013-05-27 Н.В. Нютрисиа Высокоэнергетическая жидкая энтеральная питательная композиция
WO2009113845A1 (en) 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
EP2165713B1 (de) * 2008-09-19 2012-11-14 Nestec S.A. Molke und Verbesserung der Thymusfunktion
EP2374452B1 (de) * 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nährstoffzusammensetzung
WO2011021926A1 (en) 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
IT1397446B1 (it) * 2010-01-12 2013-01-10 Professional Dietetics Srl Compositions comprising amino acids for prevention and/or treatment of renal disorders.
US20110274678A1 (en) * 2010-05-07 2011-11-10 Kourosh Dibadj Beverage
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
JP6555122B2 (ja) * 2013-02-26 2019-08-07 味の素株式会社 栄養組成物
CN104394857B (zh) 2013-05-08 2018-02-23 甘布罗伦迪亚股份公司 透析制剂
US10130603B2 (en) 2013-11-05 2018-11-20 Colgate-Palmolive Company Methods and compositions for improving kidney function
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US12109254B2 (en) 2017-11-29 2024-10-08 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
EP3716966A4 (de) 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. Alpha-ketosäurezusammensetzungen zur behandlung von hypoalbuminämie
WO2019155336A1 (en) * 2018-02-08 2019-08-15 Societe Des Produits Nestle S.A. Mct-based nutrition blend for providing health benefits in companion animals
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US12558370B2 (en) 2018-06-12 2026-02-24 Kate Farms, Inc. Intact pea protein-based nutrient composition
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
US11412771B2 (en) * 2019-04-12 2022-08-16 The Amino Company LLC Composition to improve athletic performance by supporting muscle protein synthesis and mental focus
EP3799724B1 (de) * 2019-10-02 2022-08-17 Hull, Edgar, L., Jr. Vitamine und alpha-ketosäure-zusammensetzungen zur verwendung in einem behandlungsprogramm für patienten mit chronischen nierenerkrankungen
WO2021106408A1 (ja) * 2019-11-29 2021-06-03 森永乳業株式会社 経腸摂取用組成物
CL2019003831A1 (es) 2019-12-24 2020-06-05 Univ Antofagasta Producto alimenticio tipo snack hiperproteico conteniendo proteínas con alto valor biológico (avb) para pacientes que sufren hemodiálisis.
US12115211B2 (en) 2020-10-02 2024-10-15 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
EP4000611A1 (de) * 2020-11-16 2022-05-25 ScandiBio Therapeutics AB Substanzen zur behandlung von hyperurikämie
KR102574939B1 (ko) * 2021-01-20 2023-09-07 라이프 샐러드 주식회사 신장 비투석 환자용 쉐이크 파우더 및 그 제조 방법
KR102574938B1 (ko) * 2021-01-20 2023-09-07 라이프 샐러드 주식회사 신장 투석 환자용 쉐이크 파우더 및 그 제조 방법
WO2023066832A1 (en) * 2021-10-21 2023-04-27 Société des Produits Nestlé S.A. Composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7004843A (de) * 1969-04-03 1970-10-06
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
US4898879A (en) * 1981-06-29 1990-02-06 Baxter International Inc. Nurtitional composition for management of hepatic failure
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5294642A (en) * 1989-11-30 1994-03-15 Clintec Nutrition Co. Method for improving ventilation during sleep and treating sleep related ventilation abnormalities
DE4002204A1 (de) * 1990-01-26 1991-08-01 Westfalen Milchwerke Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure

Also Published As

Publication number Publication date
DE69627748D1 (de) 2003-06-05
US5728678A (en) 1998-03-17
EP0747395B1 (de) 2003-05-02
CA2177195C (en) 2012-04-17
CA2177195A1 (en) 1996-12-07
JPH0920678A (ja) 1997-01-21
EP0747395A1 (de) 1996-12-11
ES2198459T3 (es) 2004-02-01
DE69627748T2 (de) 2004-03-25

Similar Documents

Publication Publication Date Title
ATE239037T1 (de) Zusammensetzung zur behandlung von nierenversagen
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69305105D1 (de) Zusammensetzungen zur oralen Nahrungsmittelaufnahme mit verbessertem Geschmack
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
DK0961552T3 (da) Næringstilskud til pædiatriske patienter
NO881542D0 (no) Kondisjoneringsvaesker av tann- eller benstoff.
FI970703A0 (fi) Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
DE59007518D1 (de) Sterilfiltrierte Kolostralmilch.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
NO933044L (no) Fremgangsmaate for behandling av osteoporose
DE69002201D1 (de) Formulierung zur behandlung der nierenkrankheiten.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69631656D1 (de) Debromhymenialdisin und verwandte verbindungen zur behandlung von osteoarthritis
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
BG102814A (en) New derivatives of carboxylic acid, their preparation and application
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE69314590D1 (de) Behandlung von Proteinhaltigen Körperflüssigkeiten
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
DE69531952D1 (de) Verwendung des erythropoietins zur behandlung von rheumatoider arthritis
ATE249837T1 (de) Caspase 8-inhibitoren zur immunsuppression
ATE81972T1 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
DE68903930D1 (de) Lipidemulsion zur behandlung von aids.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties